Page last updated: 2024-09-05

roxifiban and Angor Pectoris

roxifiban has been researched along with Angor Pectoris in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cain, VA; Daly, RN; Ebling, W; Gussak, I; Kopecky, SL; Murphy, J; Pieniaszek, HJ; Simonson, K; Sy, SK; Wilcox, RA; Williams, B; Wright, RS	1

Trials

1 trial(s) available for roxifiban and Angor Pectoris

Article	Year
The use of roxifiban (DMP754), a novel oral platelet glycoprotein IIb/IIIa receptor inhibitor, in patients with stable coronary artery disease. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2003, Volume: 3, Issue:2 Topics: Aged; Amidines; Angina Pectoris; Bleeding Time; Coronary Artery Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex	2003

Article

Year

The use of roxifiban (DMP754), a novel oral platelet glycoprotein IIb/IIIa receptor inhibitor, in patients with stable coronary artery disease.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2003, Volume: 3, Issue:2

Topics: Aged; Amidines; Angina Pectoris; Bleeding Time; Coronary Artery Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex

2003